Authors
1
Ministry of Health \ Al-Sader Medical City\ Najaf Governorate \ Iraq.
2
Internal Medicine, College of Medicine, University of Kufa, Najaf, Iraq.
Abstract
BACKGROUND:
Coronaviruses are microorganisms of animal and mankind. The WHO categorized the disease as COVID-19 in February, 2020.
Various laboratory markers can support the identification and follow up of COVID-19 case. Current evidence proposes a prognostic impact of neutrophil-lymphocyte ratio (NLR) in diverse inflammatory syndromes. Hence, it is rationalized to investigate its role as a prognostic biomarker in severe COVID‐19 pneumonia.
OBJECTIVE:
The objective is to analyze the effect of NLR, D-dimer, CRP, and ferritin role in the prediction of consequence of inpatients with severe COVID-19.
METHOD OF THE STUDY:
A retrospective cross-sectional study was conducted on 96 patients aged (18-80) years whom PCR SARS-CoV-2 positive, and admitted to (Al-Sader Medical City) in Al-Najaf City, Iraq between (July to October 2020).
The absolute number of neutrophil count divided by the absolute number of lymphocyte count is measured on admission to determine the value of (NLR). Parameters like (D-dimer, C-reactive protein, and ferritin) also have been investigated in relation to outcome.
RESULT:
High (NLR) was significantly (p-value = 0.001) linked with lower oxygen concentration and worse prognosis.
CONCLUSION:
Raised (NLR) was a convenient indicator connected with unfortunate outcome in those admitted with COVID-19. High inflammatory markers, like ferritin, CRP, and D-dimer were also associated with doomed prognosis.
- World Health Organization. Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
- Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI, Ishihara T, Iwata M, Morise Z, Doi Y. Natural History of Asymptomatic SARS-CoV-2 Infection. New England Journal of Medicine. 2020.
- Bajema KL, Oster AM, McGovern OL, Lindstrom S, Stenger MR, Anderson TC, Isenhour C, Clarke KR, Evans ME, Chu VT, Biggs HM. Persons evaluated for 2019 novel coronavirus—United States, January 2020. Morbidity and Mortality Weekly Report. 2020;69:166.
- Patel A, Jernigan DB. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020. Morbidity and Mortality Weekly Report. 2020;69:140.
- Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL Score. Clinical Infectious Diseases. 2020 .
- Elza Rechtman1, Paul Curtin1, Esmeralda Navarro1, Sharon Nirenberg2 & Megan K. Horton vital signs assessed in initial clinicalencounters predict COVID 19 mortality in an NYC hospitalsystem. Scientifc Reports | 2020; 10:21545.
- Ai-Ping Yang, Jian-ping Liu, Wen-qiang Tao, Hui-ming Li. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International Immunopharmacology 84 (2020) 106504.
- Zhang, P. Zou, H. Gao, M. Yang. Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study, Ther. Clin. Risk Manag. 2019
- N Zhu, D Zhang, W Wang. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med (2020) published online Jan 24.
- Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020.
- Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020; 21:74.
- Liu Z., Long W., Tu M., Chen S., Huang Y., Wang S., Zhou W., Chen D., Zhou L., Wang M., Wu M., Huang Q., Xu H., Zeng W., Guo L. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J. Infect. 2020.
- Lagunas-Rangel FA. Lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol. 2020.
- Matsumoto H., Kasai T., Sato A., Ishiwata S., Yatsu S., Shitara J. Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure. Heart Vessels. 2019;34:1961–68. doi: 10.1007/s00380-019-01435-9
- Hai-Han Yu1, Chuan Qin1, Man Chen, Wei Wang, Dai-Shi Tian, D-dimer level is associated with the severity of COVID-19. Thrombosis Research195,2020:219–25.
)
